← FDA Drug Approvals (Drugs@FDA)

INVOKAMET XR

NDA · New Drug Application · Sponsor: JANSSEN PHARMS · Approved 2016-09-20

Drug application

FDA Application #

NDA205879

Application type

New Drug Application

Brand name

INVOKAMET XR

Generic name

CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE

Active ingredients

CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

JANSSEN PHARMS

Manufacturer

Janssen Pharmaceuticals, Inc.

First approval

2016-09-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown